Palliative Care and Phase 1 Trials: Intervention to Improve Quality of Life and Provide Education

Betty R. Ferrell Vincent Chung

Marianna Koczywas

Anna Cathy Williams

Denise Gallagher

Patricia Fischer

Thomas J. Smith

palliative care, phase 1 clinical trials, quality of life, symptom burden
CJON 2017, 21(4), 473-479. DOI: 10.1188/17.CJON.473-479

Background: Patients in phase 1 clinical trials often have significant symptom burdens and quality-of-life concerns that increase as they progress along the cancer trajectory and experience drug toxicities from the clinical trial.

Objectives: The interdisciplinary intervention described is aimed at providing optimum palliative care to support patients with solid tumors participating in a phase 1 clinical trial.

Methods: The intervention includes a baseline evaluation using quantitative surveys, a comprehensive palliative care assessment by a research nurse based on patient baseline evaluation, and a goals-of-care discussion by the treating oncologist. The second component includes an interdisciplinary meeting where palliative care recommendations are made, followed by two patient education sessions.

Findings: The initial experience with the palliative care intervention suggests a need for support for this population, as well as potential benefits from integrating palliative care for patients enrolled in phase 1 clinical trials.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.